Prostate Cancer - Results from #19100

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil - Abstract March 2, 2015

Dosimetric analysis of urethral strictures following HDR (192)Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer - Abstract March 2, 2015

The association of tea consumption and the risk and progression of prostate cancer: A meta-analysis - Abstract March 2, 2015

Long-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer - Abstract March 2, 2015

Dystrophic calcification of the prostate after cryotherap - Abstract March 2, 2015

Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the reevaluation of biopsy microfocal tumor - Abstract March 2, 2015

Evidence for molecular differences in prostate cancer between African American and Caucasian men - Abstract February 28, 2015

#GU15 - Characteristics of African Americans (AAs) treated with sipuleucel-T (sip-T): Comparison of clinical trial and real-world experience - Session Highlights February 28, 2015

#GU15 - Correlation of baseline serum testosterone and PSA at 7 months in patients with new metastatic prostate cancer treated with continuous ADT - Session Highlights February 27, 2015

#GU15 - Treatment patterns of new metastatic castration-resistant prostate cancer (mCRPC) therapies: Real-world evidence from three datasets - Session Highlights February 27, 2015

#GU15 - AR modulation optimized for response in splice variant (ARMPR3-SV): A RCT of galeterone vs enzalutamide in men expressing ARv7 in mCRPC - Session Highlights February 27, 2015

#GU15 - Association between PSA declines at 4 weeks and OS in patients treated with abiraterone acetate (AA) for metastatic castration resistant prostate cancer (mCRPC) after docetaxel - Session Highlights February 27, 2015

#GU15 - Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone - Session Highlights February 27, 2015

#GU15 - The impact of time to metastasis on survival in treatment-naïve prostate cancer patients - Session Highlights February 27, 2015

A multidisciplinary clinic to mitigate the impact of androgen deprivation therapy in prostate cancer: A pilot study - Session Highlights February 27, 2015

#GU15 - Best of journals: mCRPC treatment - Session Highlights February 27, 2015

A dose-response analysis of biochemical control outcomes after (125)i monotherapy for patients with favorable-risk prostate cancer - Abstract February 27, 2015

Periprostatic fat thickness on MRI: Correlation with Gleason score in prostate cancer - Abstract February 27, 2015

Surface-enhanced Raman spectroscopy + support vector machine: A new noninvasive method for prostate cancer screening? - Abstract February 27, 2015

Laparascopic radical prostatectomy - Abstract February 27, 2015

Page 956 of 1458